To truly improve patients’ clinical outcomes, digital
biomarker devices need to go beyond the delivery of
interesting data to generate actionable insights. It’s
about making the shift from descriptive to predicative
analytics. The companies creating devices which
make this transition are set to play a key role in the
burgeoning digital therapeutics space. In this paper,
we look at how advanced digital biomarker devices can
enable earlier evidence-based interventions to treat,
manage or prevent medical disorders and disease.

Ongoing innovation in digital biomarker devices heralds a new age of more
intelligent and personalised treatments and care plans. These devices have
the potential to significantly improve the effectiveness and cost-efficiency
of healthcare, for developed and developing nations alike. However, to make
a meaningful difference to patient experiences and outcomes, they need to
do more than monitor an individual’s condition. They also need to analyse
and leverage biomarker data to generate actionable insights that healthcare
professionals and patients can use to inform decisions as they progress
along treatment plans.